Hubert S. Chou

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
PURPOSE In addition to lowering hemoglobin A1C, colesevelam has been shown to improve the atherogenic lipoprotein profile of subjects with type 2 diabetes mellitus (T2DM) when used in combination with metformin and/or sulfonylureas. A recent study evaluated the effects of colesevelam as antidiabetes monotherapy in adults with T2DM who had inadequate(More)
  • 1